AMD3100, an antagonist of CXCR4 and mobilizer of myeloid progenitor cells, is a potent mobilizer of competitive repopulating long term marrow self-renewing stem cells in mice.

被引：0
|
作者：
Broxmeyer, HE
Hangoc, G
Cooper, S
Li, XX
Bridger, G
Clapp, DW
机构：
[1] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Wells Ctr Pediat Res, Indianapolis, IN USA
[3] Walther Canc Inst, Indianapolis, IN USA
[4] AnorMED Inc, Langley, BC, Canada
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2397
引用
收藏
页码：609A / 609A
页数：1
相关论文
共 25 条
  • [1] Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
    Liles, WC
    Broxmeyer, HE
    Rodger, E
    Wood, B
    Hübel, K
    Cooper, S
    Hangoc, G
    Bridger, GJ
    Henson, GW
    Calandra, G
    Dale, DC
    BLOOD, 2003, 102 (08) : 2728 - 2730
  • [2] Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
    Broxmeyer, HE
    Orschell, CM
    Clapp, DW
    Hangoc, G
    Cooper, S
    Plett, PA
    Liles, WC
    Li, XX
    Graham-Evans, B
    Campbell, TB
    Calandra, G
    Bridger, G
    Dale, DC
    Srour, EF
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08): : 1307 - 1318
  • [3] The CXCR4 antagonist AMD3100 and the CXCR2 agonist GROβ synergistically mobilize hematopoetic stem cells (HSC) with short and long term repopulating activity.
    Pelus, Louis M.
    Fukuda, Seiji
    Bridger, Gary
    BLOOD, 2006, 108 (11) : 105A - 105A
  • [4] A pharmacokinetic/pharmacodynamic profile of the CXCR4 antagonist AMD3100 for the mobilization of hematopoietic progenitor cells.
    Lack, NA
    Dale, DC
    Calandra, G
    MacFarland, RT
    Badel, K
    Liles, WC
    BLOOD, 2003, 102 (11) : 115A - 115A
  • [5] Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100
    Bonig, Halvard
    Chudziak, Doreen
    Priestley, Greg
    Papayannopoulou, Thalia
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (03) : 402 - 415
  • [6] The CXCR4 receptor antagonist AMD3100 does not prevent homing and engraftment of murine syngeneic bone marrow stem cells.
    van Os, R
    Schols, D
    Struyf, S
    De Clercq, E
    Willemze, R
    Fibbe, WE
    BLOOD, 2000, 96 (11) : 308B - 308B
  • [7] AMD3100, a CXCR4 antagonist, augments mobilization and incorporation of bone marrow-derived endothelial progenitor cells into sites of myocardial neovascularization
    Iwakura, A
    Luedemann, C
    Kusano, K
    Takenaka, H
    Eaton, E
    Bridger, G
    Losordo, DW
    CIRCULATION, 2003, 108 (17) : 159 - 159
  • [8] INHIBITORY EFFECT OF AMD3100 ON APOE-/- MICE BONE MARROW ENDOTHELIAL PROGENITOR CELLS COLONY FORMING ABILITY AND CXCR4 EXPRESSION
    Wang, Z.
    Zhou, X.
    Zhang, X.
    Jiang, Z.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [9] Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells
    van Gosliga, Djoke
    Schepers, Hein
    Rizo, Aleksandra
    van der Kolk, Dorina
    Vellenga, Edo
    Schuringa, Jan Jacob
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (10) : 1538 - 1549
  • [10] CXCR4 Antagonist AMD3100 Preserves Cardiac Function After Ischemia-Reperfusion Injury via eNOS Dependent Mobilization of Bone Marrow Derived Progenitor Cells
    Jujo, Kentaro
    Klyachko, Ekaterina
    Misener, Sol
    Thorne, Tina
    Ii, Masaaki
    Sekiguchi, Haruki
    Tanaka, Toshikazu
    Tongers, Joern
    Roncalli, Jerome
    Clarke, Trevor
    Ito, Aiko
    Kamide, Christine
    Tsurumi, Yukio
    Hagiwara, Nobuhisa
    Qin, Gangjian
    Losordo, Douglas W.
    CIRCULATION, 2009, 120 (18) : S852 - S852
123